hERG, Plasmodium life cycle, and cross resistance profiling of new azabenzimidazole analogues of astemizole

Please be advised that the site will be down for maintenance on Sunday, September 1, 2024, from 08:00 to 18:00, and again on Monday, September 2, 2024, from 08:00 to 09:00. We apologize for any inconvenience this may cause.

Show simple item record

dc.contributor.author Mambwe, Dickson
dc.contributor.author Coertzen, Dina
dc.contributor.author Leshabane, Meta Kgaogelo
dc.contributor.author Mulubwa, Mwila
dc.contributor.author Njoroge, Mathew
dc.contributor.author Gibhard, Liezl
dc.contributor.author Girling, Gareth
dc.contributor.author Wicht, Kathryn J.
dc.contributor.author Lee, Marcus C.S.
dc.contributor.author Wittlin, Sergio
dc.contributor.author Moreira, Diogo Rodrigo Magalhaes
dc.contributor.author Birkholtz, Lyn-Marie
dc.contributor.author Chibale, Kelly
dc.date.accessioned 2024-07-25T07:10:15Z
dc.date.available 2024-07-25T07:10:15Z
dc.date.issued 2024-03
dc.description SUPPLEMENTARY INFORMATION : Experimental procedures and characterization data of synthetic intermediates (5a–5f, 6a–6f, 13, and 15) and target compounds (7–12 and 15); biochemical assay protocols, including solubility and cross-resistance studies; H NMR spectra of representative target compounds. en_US
dc.description.abstract Please read abstract in the article. en_US
dc.description.department Biochemistry en_US
dc.description.department Genetics en_US
dc.description.department Microbiology and Plant Pathology en_US
dc.description.department UP Centre for Sustainable Malaria Control (UP CSMC) en_US
dc.description.librarian hj2024 en_US
dc.description.sdg SDG-03:Good heatlh and well-being en_US
dc.description.sponsorship The University of Cape Town (UCT), South African Medical Research Council, the South African Research Chairs Initiative (SARChI) of the Department of Science and Innovation (DSI) administered through the South African National Research Foundation (NRF), the Brazilian National Council for Scientific and Technological Development, Proep-Fiocruz Program (Brazil), the Neville Isdell Chair in African-centric Drug Discovery and Development, and Neville Isdell for generously funding the Chair. en_US
dc.description.uri http://pubs.acs.org/journal/amclct en_US
dc.identifier.citation Mambwe, D., Coertzen, D., Leshabane, M. et al. 2024, 'hERG, Plasmodium life cycle, and cross resistance profiling of new azabenzimidazole analogues of astemizole', ACS Medicinal Chemistry Letters, vol. 15, no. 4, pp. 463-469, doi : 10.1021/acsmedchemlett.3c00496. en_US
dc.identifier.issn 1948-5875 (print)
dc.identifier.other 10.1021/acsmedchemlett.3c00496
dc.identifier.uri http://hdl.handle.net/2263/97228
dc.language.iso en en_US
dc.publisher American Chemical Society en_US
dc.rights © 2024 The Authors. Published by American Chemical Society. This article is licensed under CC-BY 4.0. en_US
dc.subject Astemizole en_US
dc.subject Plasmodium falciparum en_US
dc.subject Plasmodium berghei en_US
dc.subject Repositioning en_US
dc.subject Human ether-á-go-go-related gene (hERG) en_US
dc.subject Gametocytocidal en_US
dc.subject Liver-stage activity en_US
dc.subject Resistance phenotypes en_US
dc.subject SDG-03: Good health and well-being en_US
dc.title hERG, Plasmodium life cycle, and cross resistance profiling of new azabenzimidazole analogues of astemizole en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record